How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Alan Turing was one of the most influential British figures of the 20th century. In 1936, Turing invented the computer as part of his attempt to solve a fiendish puzzle known as the ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

Natural selection uses duplicated genes as raw material for functional innovation, co-opting their existing features to new functions. Understanding genetic innovation requires two questions to be ...

A June 2026 research review found that AI chatbot warning labels may be a weak safeguard for organization-backed AI advisors, raising new audit questions for IT, security, and compliance teams. If you ...

Need to scan, copy, or fax, in addition to printing? An AIO printer is what you want. Find the right multifunction machine based on our in-depth reviews and expert advice. Most of my current work for ...

How machine intelligence changes the rules of business by Marco Iansiti and Karim R. Lakhani In 2019, just five years after the Ant Financial Services Group was launched, the number of consumers using ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.